The strange origin story of psychedelics in Saskatchewan
Sep 29, 2024
auto_awesome
Discover how Saskatchewan became an unlikely hub for psychedelic research in the 1950s. Unearth the groundbreaking experiments at the Weyburn Mental Hospital, where doctors delved into altered states for therapeutic purposes. Explore the promising use of psychedelics like LSD in addiction recovery, offering transformative insights. Delve into the cultural and economic factors that led to their criminalization and the recent renaissance in mental health treatment. It's a captivating journey through the evolving landscape of psychedelics and psychiatry.
In the 1950s, Saskatchewan, particularly the Weyburn Mental Hospital, became a hub for psychedelic research aimed at understanding mental illness treatment.
The shifting public perception and regulatory changes in the late 1960s hindered further psychedelic research, but recent trends suggest a resurgence in therapeutic interest.
Deep dives
Historical Context of Psychedelic Research in Saskatchewan
In the 1950s, Saskatchewan became a focal point for groundbreaking psychedelic research, particularly at the Weyburn Mental Hospital. This facility, described as a large asylum, housed patients under challenging conditions, often leading to high rates of patient mortality. Humphrey Osman, a British-trained psychiatrist, arrived at the hospital in 1951 and was determined to change the prevailing treatment methods for mental disorders. He sought to explore the use of psychedelics such as LSD and mescaline, not just for their therapeutic potential but also as a means to understand the experiences of patients with mental illnesses.
Innovative Approaches to Mental Health Treatment
Osman’s research involved administering psychedelics to both medical professionals and patients, aiming to foster a deeper understanding of mental illnesses and provide insights into various psychiatric conditions. Through these treatments, he hoped that individuals could transcend their mental barriers and find empathic connections to their own experiences and those of others. An important aspect of this exploration was the combination of these psychedelics with traditional therapeutic practices, with Osman theorizing that these substances could significantly enhance psychotherapeutic outcomes. This interdisciplinary approach aimed to create profound psychological breakthroughs, especially for individuals grappling with addiction issues.
The Shift in Perception and Regulation of Psychedelics
Despite the promising results of psychedelic therapies in treating mental health issues, including addiction, the public perception of these substances began to shift dramatically in the late 1960s. Cultural changes, regulatory frameworks, and moral panics surrounding drug use led to the criminalization of psychedelics, overshadowing their potential therapeutic benefits. As scientific methodologies advanced, psychedelics were increasingly excluded from legitimate medical research, in part due to challenges in measuring their effects through standardized clinical trials. However, in recent years, there has been a resurgence of interest in these substances as potential treatments for mental health disorders, reflecting a possible cultural reconciliation with their use in modern medicine.
For this Sunday's look-back episode, we're revisiting an interview from January 2022 about a psychedelic renaissance taking place in an unlikely locale.
In the 1950s, before they fuelled the acid-trips of the '60s, psychedelics were being passed around the Weyburn Mental Hospital in Saskatchewan. And not just among the patients—as well as being given to those struggling with mental illness, doctors and their spouses were using them on themselves—for "research purposes".
How did Saskatchewan become the world's psychedelic hub? What did we learn there that would inform the rise in use and then strict enforcement of these drugs in the decades to come? And how can it help us understand why these drugs are now making a return to therapy?
GUEST: Erika Dyck, historian of health, medicine, and Canadian society at the University of Saskatchewan and Canada Research Chair in the History of Medicine; author of Psychedelic Psychiatry: LSD on the Canadian Prairies
We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: